The AI2Health cluster of the Ken Kennedy Institute and the Synthetic Biology Institute at Rice University hosted a debriefing and collaborative discussion session on the Spirit of Asilomar summit June ...

The development of early monoclonal antibody (mAb) therapies centered around the hybridoma platform requires the production of target antigen or immunogen and animal immunizations. This means there ...

Professor Emeritus Herb Boyer's discovery of recombinant DNA changed medicine, ushering in a new era in biological treatments and led to the creation of synthetic insulin. It also changed the way ...

Elena Erroba is the group CCO at 3PBIOVIAN. She specializes in the development and manufacturing of recombinant proteins and advanced therapies, including viral vectors—such as adenoviruses and ...

Market to grow from USD 2.58 Billion in 2024 to USD 6.38 Billion by 2032, at a CAGR of 12.02%.Austin, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Human Growth Hormone Market Size & Growth Analysis According to ...

The CDSCO's expert panel consented for firm's proposal for discontinuation of products noting that alternative therapies are ...

Recombinant Proteins Market Recombinant proteins are at the heart of modern biopharmaceutical innovation, enabling breakthroughs in drug d ...

A new study in the journal Human Gene Therapy indicates that DNA impurities derived from plasmid and host cell DNA are encapsulated into recombinant adeno-associated virus (rAAV) capsids as single ...

The blood purification technology is used for the treatment of severe treatment-refectory systematic lupus erythematosus (SLE).

Endotoxin testing is critical for quality control in drug production, as it has a direct impact on pharmaceutical safety and effectiveness. Traditionally Limulus Amebocyte Lysate (LAL) testing is used ...